References: Autologous hematopoetic cell transplantation: preferred consolidation treatment in low-risk AML?

131

Views

CrossRef citations to date

Altmetric

References

Beyar-Katz O, Lavi N, Ringelstein-Harlev S, et al. Superior outcome of patients with favorable-risk acute myeloid leukemia using consolidation with autologous stem cell transplantation. Leuk Lymphoma. 2019;60:2449–2456.
PubMed Web of Science ®Google Scholar
Vellenga E, van Putten W, Ossenkoppele GJ, et al. Autologous peripheral blood stem cell transplantation for acute myeloid leukemia. Blood. 2011;118:6037–6042.
PubMed Web of Science ®Google Scholar
Christopeit M, Labopin M, Gorin NC, et al. Allogeneic stem cell transplantation following relapse post autologous stem cell transplantation in adult patients with acute myeloid leukemia: a retrospective analysis of 537 patients from the Acute Leukemia Working Party of the EBMT. Am J Hematol. 2018;93:1532–1542.
PubMed Web of Science ®Google Scholar
Passweg JR, Labopin M, Christopeit M, et al. Impact of consolidation by autologous HCT as compared to chemotherapy on toxicity of subsequent allogeneic HCT in CR2 in patients with AML. Presented at the EBMT 2019 conference; 2019 Mar 25; Frankfurt, Germany.
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Autologous hematopoetic cell transplantation: preferred consolidation treatment in low-risk AML?

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Autologous hematopoetic cell transplantation: preferred consolidation treatment in low-risk AML?

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date